Yanjun Liu

Dr. Yanjun Liu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2020 in Cell Death & Disease
Verified
Journal Article
Open access
TZTongtong Zhang
Tongtong Zhang
HLHongtao Liu
Hongtao Liu
RMRui Mao
Rui Mao
HYHuawu Yang
Huawu Yang
YZYuanchuan Zhang
Yuanchuan Zhang
YLYanjun Liu
Yanjun Liu
Emerging evidence suggests that long noncoding RNAs (lncRNAs) play essential roles in the regulation of gene expression. However, the functional contributions of lncRNAs to adipogenesis remain largely unexplored. In this study, we investigated global changes in the expression patterns of lncRNAs in visceral adipose tissue and identified RP11-142A22.4 as a significantly upregulated lncRNA. In isolated preadipocytes, knockdown of RP11-142A22.4 inhibited differentiation and reduced C/EBP-α and PPAR-γ expression. Investigations of the underlying mechanisms revealed that RP11-142A22.4 contains a functional miR-587 binding site. Mutation of the binding sites for RP11-142A22.4 in miR-587 abolished the interaction, as indicated by a luciferase reporter assay. Furthermore, RP11-142A22.4 affected the expression of miR-587 and its target gene Wnt5β. Overexpression of miR-587 blocked the inhibitory effect of RP11-142A22.4 on preadipocyte differentiation. Moreover, the downregulation of miR-587 restored preadipocyte differentiation upon inhibition by RP11-142A22.4 silencing. Our results suggest that RP11-142A22.4 can control adipocyte differentiation via the miR-587/Wnt5β signaling pathway and serve as a potential target for obesity treatments.

17 March 2025 in Materials Today Bio
Verified
Journal Article
Open access
ZCZhiguang Chen
Zhiguang Chen
LSLiang Sang
Liang Sang
QZQixi Zhai
Qixi Zhai
XLXiang Li
Xiang Li
YLYanjun Liu
Yanjun Liu
ZBZhiQun Bai
ZhiQun Bai
Central nervous system (CNS) cancers, particularly glioblastoma (GBM), are associated with high mortality and disability rates. Despite aggressive surgical resection, radiotherapy, and chemotherapy, patient survival remains poor. The blood-brain barrier (BBB) significantly impedes therapeutic efficacy, making BBB penetration a critical focus of research. Focused ultrasound (FUS) combined with microbubbles (MBs) can transiently open the BBB through mechanisms such as cavitation, modulation of tight junction protein expression, and enhanced vesicular transport in endothelial cells. This review highlights precision delivery and personalized treatment strategies under ultrasound visualization, including precise control of ultrasound parameters and modulation of the immune microenvironment. We discuss the applications of ultrasound-responsive nanoparticles in brain tumor therapy, including enhanced radiotherapy, gene delivery, immunotherapy, and sonodynamic therapy (SDT), with a particular emphasis on piezoelectric catalytic immunotherapy. Finally, we provide insights into the clinical translation potential of ultrasound-responsive nanoparticles for personalized and precision treatment of brain tumors.

9 May 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
ZCZhiguang Chen
Zhiguang Chen
LSLiang Sang
Liang Sang
DBDonglin Bian
Donglin Bian
YLYanjun Liu
Yanjun Liu
ZBZhiqun Bai
Zhiqun Bai
Over the past decade, immunotherapy has revolutionized the clinical management of numerous cancer types. However, only a subset of patients derives long-term durable tumor control from it. Intriguingly, several emerging therapeutic strategies harnessing reactive oxygen species (ROS)-mediated immunogenic cell death (ICD) hold promise for enabling precision immunotherapy in cancer, with sonodynamic therapy emerging as a notable example. The utilization of piezoelectric materials as sonosensitizers can effectively enhance ROS production, thereby augmenting the efficacy of ICD-induced immunotherapy. Additionally, electrical stimulation generated by the piezoelectric effect can further induce immune response activation and necroptosis, achieving a synergistic effect in piezo-catalytic immunotherapy. Herein, we will systematically review the pathways and potential mechanisms underlying piezo-catalytic immunotherapy, offering novel insights for the exploration of cancer immunotherapy strategies.

24 October 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YYYuting Yang
Yuting Yang
YCYuan Cheng
Yuan Cheng
ZCZhiguang Chen
Zhiguang Chen
YLYanjun Liu
Yanjun Liu
Ultrasound-responsive micro/nanobubbles (MNBs) are promising tools for targeted cancer therapy due to their controllable acoustic activation and real-time imaging. Despite extensive research, the quantitative relationship between bubble structure, acoustic response, and therapeutic efficacy remains poorly understood. This knowledge gap hinders parametric design and clinical standardization. This review summarizes recent advances from an engineering perspective, highlighting how structural parameters—such as size, shell, gas core, and ligand density—affect acoustic sensitivity and drug release. Furthermore, the roles of microfluidic electroporation and cell membrane coating are discussed in terms of controllable fabrication and preservation of biological functions, highlighting their significance for reproducible and predictable therapies. In conclusion, this review establishes a “Structure-Response-Efficacy (S-R-E)” framework to summarize the core relationships between structural design and acoustic modulation. We propose an engineering strategy based on a standardized parameter system to guide the predictable design and clinical translation of ultrasound-based theranostic platforms.


19 April 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCSiqi Cao
Siqi Cao
XLXingzhe Li
Xingzhe Li
XZXin Zheng
Xin Zheng
JZJiaxin Zhang
Jiaxin Zhang
ZJZiyao Ji
Ziyao Ji
YLYanjun Liu
Yanjun Liu
This study aimed to explore potential risk factors for severe endometriosis and to develop a model to predict the risk of severe endometriosis. A total of 308 patients with endometriosis were analyzed. Least absolute shrinkage and selection operator (LASSO) was performed to identify the potential risk factors for severe endometriosis. Then, we used seven machine learning (ML) algorithms to construct the predictive models. Finally, SHapley Additive exPlanations (SHAP) interpretation was performed to evaluate the contributions of each factor to risk prediction. About 59.2% (183/308) of patients were diagnosed with severe endometriosis. The random forest (RF) model performed best in discriminative ability among the seven ML models, achieving an area under the curve (AUC) of 0.744. After reducing features according to feature importance rank, an explainable final RF model was established with six features. From the SHAP map, we found that the negative sliding sign had the greatest impact on the diagnostic performance of the RF model. This study provided a personalized risk assessment for the development of severe endometriosis, which may enable early identification of high-risk patients, facilitating timely intervention and optimized treatment strategies.